Dr Reddys Laboratories (RDY) Gross Margin (2009 - 2026)
Dr Reddys Laboratories (RDY) reported Gross Margin of 52.13% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 2.54 percentage points from 54.67% a year earlier but up 5.62 percentage points from the prior quarter.
Dr Reddys Laboratories (RDY) Gross Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Dr Reddys Laboratories' Gross Margin came in at 49.51%, down 6.94 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was 52.77%, down 5.75 percentage points from FY2025.
- Gross Margin has a five-year change of -1.55 percentage points (FY2021 to FY2026).
- By fiscal year, Gross Margin came in at 58.51% in FY2025 (-0.08 pp), 58.60% in FY2024 (+1.95 pp), 56.65% in FY2023 (+3.57 pp) and 53.08% in FY2022 (-1.24 pp).
- Five-year quarterly Gross Margin spans a low of 44.82% in fiscal Q4 2026 and a high of 60.40% in fiscal Q1 2025.
- Year over year, Gross Margin has now declined in each of the last seven quarters, with an average year-over-year change of -4.99 percentage points over the last eight quarters.
- The high point for year-over-year Gross Margin in five years was fiscal Q4 2023 (a gain of 5.83 percentage points); the low point was fiscal Q4 2026 (a drop of 10.74 percentage points).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at 46.52% (Q1 2027), 44.82% (Q4 2026) and 53.63% (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 75.71% |
| 10 | Dr Reddys Laboratories | 12.40 Bn | 11.74 Bn | 472.93 Mn | 52.13% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 52.13% |
| Jun 30, 2026 | 46.52% |
| Mar 31, 2026 | 44.82% |
| Dec 31, 2025 | 53.63% |
| Sep 30, 2025 | 54.67% |
| Jun 30, 2025 | 56.91% |
| Mar 31, 2025 | 55.56% |
| Dec 31, 2024 | 58.68% |
| Sep 30, 2024 | 59.59% |
| Jun 30, 2024 | 60.40% |
| Mar 31, 2024 | 58.57% |
| Dec 31, 2023 | 58.50% |
| Sep 30, 2023 | 58.67% |
| Jun 30, 2023 | 58.70% |
| Mar 31, 2023 | 58.69% |
| Dec 31, 2022 | 57.24% |
| Sep 30, 2022 | 59.22% |
| Jun 30, 2022 | 59.06% |
| Mar 31, 2022 | 52.87% |
| Dec 31, 2021 | 52.86% |
Dr Reddys Laboratories Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();